Fainting induces an acute increase in the concentration of plasma factor VIII and von Willebrand factor

Haematologica

Volumn 88, Issue 6, 2003, Pages 688-693

  Casonato, Alessandra ^a   Pontara, Elena ^b   Bertomoro, Antonella ^b   Cattini, Maria Grazia ^b   Soldera, Carmen ^b   Girolami, Antonio ^b  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b NONE

Author keywords

Endothelial cells; Fainting; FVIII; VWF; VWF multimers

Indexed keywords

BLOOD CLOTTING FACTOR 8; DESMOPRESSIN; OLIGOMER; POLYMER; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CASE REPORT; ENDOTHELIUM CELL; FEMALE; HEMOSTASIS; HUMAN; STRESS; SYNCOPE; THROMBOCYTE; VEIN PUNCTURE; VON WILLEBRAND DISEASE;

ADULT; FACTOR VIII; FEMALE; HEMATOLOGIC TESTS; HUMANS; PHLEBOTOMY; SYNCOPE; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 0038125962     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Luscher TF, Tanner FC. Endothelial regulation of vascular tone and growth. Am J Hypertens 1993;6:2835-35.
2. Sylvester JT, Scharf SM, Gilbert RD, Fitzgerald RS, Traystaman RJ. Hypoxic and CO hypoxia in dogs: hemodynamics, carotid reflexes and cathecholamines. Am J Physiol 1979; 236:H22-H8.
3. Thiemermann C, Szabo C, Mitchell JA, Vane JR. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc Natl Acad Sci USA 1993;90:267-71.
4. Benedict CR, Rose JA. Arterial norepinephrine changes in patients with septic shock. Circ Shock 1992;38:167-72.
5. Cumming AD, Driedger A, McDonald JWD, Lindsay RM, Solez K, Linton AL. Vasoactive hormones in the renal response to systemic sepsis. Am J Kidney Dis 1988;11:23-32.
6. Furchgott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of the arterial smooth muscle by acetylcholine. Nature 1980;288:376-83.
7. Vanhoutte PM, Rimele TJ. Role of the endothelium in the control of vascular smooth muscle function. J Physiol 1983; 78:681-6.
8. Mione MC, Ralevic V, Burnstock G. Peptides and vasomotor mechanisms. Pharmacol Ther 1990;46:429-68.
9. Monchada S, Vane VR. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin. Pharmacol Rev 1979;30:293-331.
10. Radomski MW, Palmer RM, Moncada S. The anti-aggregating properties of vascular endothelium: interaction between prostacyclin and nitric oxide. Br J Pharmacol 1987;92:639-41.
11. Ruggeri ZM, Zimmerman TS. von Willebrand factor and von Willebrand disease. Blood 1987;70:895-904.
12. Sporn LA, Marder VJ, Wagner DD. Inducible secretion of large, biologically potent von Willebrand factor multimers. Cell 1986;46:185-90.
13. Wagner DD. Cell biology of von Willebrand factor. Ann Rev Cell Biol 1990;6:217-22.
14. Mannucci PM, Ruggeri ZM, Pareti FI, Capitanio A. 1-desamino-8-d arginine vasopressin: a new pharmacological approach in the managment of hemophilia and von Willebrand disease. Lancet 1977;1:869-72.
15. Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994;71:520-5.
16. Casonato A, De Marco L, Mazzuccato M, De Angelis V, De Roia A, Fabris F, et al. A new congenital platelet abnormality characterized by spontaneous platelet aggregation, enhanced von Willebrand factor platelet interaction and the presence of all von Willebrand factor multimers in plasma. Blood 1989;74:2028-33.
17. Casonato A, Fabris F, Vicariotto M, Girolami A. The evaluation of factor VIII antigen by means of a simpe slide test. Am J Clin Path 1985;29:309-16.
18. Casonato A, Sartori MT, Pontara E, Zucchetto S, Girolami A. Impaired release of tissue plasminogen activator (t-PA) following DDAVP infusion in von Willebrand's disease with low platelet von Willebrand factor content. Blood Coagul Fibrinol 1992;3:149-53.
19. Schneppenheim R, Federici AB, Budde U, Castaman G, Drewke E, Krey S, et al. Von Willebrand disease type 2M "Vicenza" in Italian and German patients: identification of the first candidate mutation (G3864A; R1205H) in 8 families. Thromb Haemost 2000;82:136-40.
20. Casonato A, Pontara E, Sartorello F, Cattini MG, Sartori MT, Padrini R, et al. Reduced von Willebrand factor survival in type Vicenza von Willebrand disease. Blood 2002;99:180-4.
21. Wagner DD, Saffaripour S, Bonfanti R, Sadler JE, Cramer EM, Chapman B, et al. Induction of specific storage organelles by von Willebrand factor propolypeptide. Cell 1991;64:403-13.
22. Gralnick HR, Williams SB, Morisato DK. Effect of multimeric structure of the FVIII/von Willebrand factor binding protein on platelets. Blood 1981;58:387-92.
23. Federici AB, Bader R, Pagani MI, Colibretti L, De Marco L, Mannucci PM. Binding of von Willebrand factor (vWF) to glycoprotein Ib and IIb-IIIa complex: affinity is related to multimeric size. Br J Haematol 1989;73:93-9.
24. Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, et al. Unusually large plasma factor VIII/von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 1982;307:1432-5.
25. Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Hellum JD. Involvement of large von Willebrand factor (VWF) multimers and unusually large VWF forms derived from endothelial cells in shear-stress induced platelet aggregation. J Clin Invest 1986;78:1456-61.
26. Casonato A, Pontara E, Boscaro M, Sonino N, Sartorello F, Ferasin S, et al. Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome. Blood Coagul Fibrin 1999;10:145-51.
27. Ruggeri ZM, Zimmerman TS. Variant von Willebrand. Characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets. J Clin Invest 1980;65:1318-25.
28. Ingram GIC. Increase in antihemophilic globulin activity following infusion of adrenaline. J Physiol 1961;156:217-24.
29. Patrassi GM, Fallo F, Santarossa A, Sartori MT, Casonato A, Girolami A. Clotting changes in borderline hypertension. J Hum Hypertens 1987;1:101-3.
30. Mannucci PM, Canciani MT, Forza I, Lussana F, Lattuada A, Rossi E. Changes in health and disease of metalloproteases that cleaves von Willebrand factor. Blood 2001;98:2730-5.
31. Nicholas WC, Ginsburg D. Von Willebrand disease. Medicine 1997;76:1-20.